Schrodinger SDGR shares are trading higher on Monday after the company announced a collaboration with Bristol Myers Squibb in which Schrodinger will receive a $55 million upfront payment.
Schrodinger is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries.
Schrodinger shares are trading up 12.49% at $68.17 at time of publication on Monday. The stock has a 52-week high of $99.50 and a 52-week low of $25.50.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
